莱斯康制药 (LXRX.O)

+ 收藏

资产负债表(莱斯康制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年年报2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见66,656,000.0034,551,000.0035,617,000.0096,494,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见3,473,000.002,895,000.002,620,000.001,526,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见4,532,000.006,706,000.007,675,000.007,009,000.00
 存货(元) 会员可见会员可见会员可见会员可见231,000.00636,000.00585,000.00514,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见171,301,000.00223,818,000.00274,347,000.00259,104,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见246,193,000.00268,606,000.00320,844,000.00364,647,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见2,484,000.002,135,000.001,954,000.001,843,000.00
 受限制存款及现金非流动(元) 会员可见会员可见会员可见-----
 商誉(元) 会员可见会员可见会员可见会员可见44,543,000.0044,543,000.0044,543,000.0044,543,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见5,200,000.005,839,000.006,015,000.006,186,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见52,227,000.0052,517,000.0052,512,000.0052,572,000.00
总资产(元) 会员可见会员可见会员可见会员可见298,420,000.00321,123,000.00373,356,000.00417,219,000.00
流动负债:
 短期债务及长期负债本期部分(元) 会员可见--会员可见----
 应付账款及票据(元) 会员可见会员可见会员可见会员可见14,801,000.0014,201,000.0012,220,000.008,067,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见30,447,000.0021,845,000.0015,656,000.0015,332,000.00
 递延收入流动(元) -会员可见会员可见会员可见----
 流动负债合计(元) 会员可见会员可见会员可见会员可见45,248,000.0036,046,000.0027,876,000.0023,399,000.00
非流动负债:
 长期债务(元) 会员可见会员可见会员可见会员可见107,222,000.00106,565,000.00105,500,000.0099,874,000.00
 融资租赁负债非流动(元) -------5,079,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见107,222,000.00106,565,000.00105,500,000.00104,953,000.00
总负债(元) 会员可见会员可见会员可见会员可见152,470,000.00142,611,000.00133,376,000.00128,352,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见363,000.00363,000.00363,000.00248,000.00
 优先股(元) -------23,000.00
 库存股(元) 会员可见会员可见会员可见会员可见-4,615,000.00-4,615,000.00-4,615,000.00-4,615,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见2,117,325,000.002,115,891,000.002,113,090,000.002,108,497,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-1,967,242,000.00-1,933,476,000.00-1,868,665,000.00-1,815,236,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见119,000.00349,000.00-193,000.00-50,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见145,950,000.00178,512,000.00239,980,000.00288,867,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见145,950,000.00178,512,000.00239,980,000.00288,867,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见298,420,000.00321,123,000.00373,356,000.00417,219,000.00
公告日期 2026-03-052025-11-062025-08-062025-05-142025-03-072024-11-132024-08-022024-05-02
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院